The oncogenic ROS1 gene fusion in lung adenocarcinomas, which is identified in up to 3.4% of patients, has expanded the list of themolecular subsets of lung cancers [21–23, 28–30]. This evidence concerns the gene ROS1 and lung adenocarcinoma.